MedAvail Holdings (STU:73M) Return-on-Tangible-Asset: -71.32% (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:73M MedAvail Holdings Inc STU:73M
12 GF Score
Price €11.05
View Full Analysis

What is MedAvail Holdings Return-on-Tangible-Asset?

MedAvail Holdings STU:73M 12 Return-on-Tangible-Asset is -71.32% as of Jun. 2023. GuruFocus rates STU:73M with a GF Score™ of 12/100.

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. MedAvail Holdings's annualized Net Income for the quarter that ended in Jun. 2023 was €-21.38 Mil. MedAvail Holdings's average total tangible assets for the quarter that ended in Jun. 2023 was €29.98 Mil. Therefore, MedAvail Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2023 was -71.32%.

The historical rank and industry rank for MedAvail Holdings's Return-on-Tangible-Asset or its related term are showing as below:

STU:73M's Return-on-Tangible-Asset is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.51
* Ranked among companies with meaningful Return-on-Tangible-Asset only.

MedAvail Holdings  (STU:73M) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


MedAvail Holdings Return-on-Tangible-Asset Related Terms


MedAvail Holdings Return-on-Tangible-Asset Historical Data

* Premium members only.

The historical data trend for MedAvail Holdings's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedAvail Holdings Return-on-Tangible-Asset Chart

MedAvail Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Return-on-Tangible-Asset
-120.07 -60.43 -87.61 -143.70

MedAvail Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -126.84 -99.33 -105.04 -202.97 -71.32

STU:73M vs HEWA, BIMI, MEDS: Return-on-Tangible-Asset Comparison

For the Pharmaceutical Retailers subindustry, MedAvail Holdings's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedAvail Holdings Return-on-Tangible-Asset vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MedAvail Holdings's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where MedAvail Holdings's Return-on-Tangible-Asset falls into.


STU:73M
12GF Score
MedAvail Holdings Inc STU:73M
Return-on-Tangible-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MedAvail Holdings Return-on-Tangible-Asset Calculation

MedAvail Holdings's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2022 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=-44.95/( (31.721+30.838)/ 2 )
=-44.95/31.2795
=-143.70 %

MedAvail Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Jun. 2023 )  (Q: Mar. 2023 )(Q: Jun. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Jun. 2023 )  (Q: Mar. 2023 )(Q: Jun. 2023 )
=-21.38/( (32.96+26.999)/ 2 )
=-21.38/29.9795
=-71.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Jun. 2023) net income data.

What does a Return-on-Tangible-Asset of -71.32% mean?
MedAvail Holdings (STU:73M) has a Return-on-Tangible-Asset of -71.32% as of Jun. 2023. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on MedAvail Holdings and its competitors.
Is MedAvail Holdings' Return-on-Tangible-Asset too high?
MedAvail Holdings' current Return-on-Tangible-Asset is -71.32%. Overall, MedAvail Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does MedAvail Holdings' Return-on-Tangible-Asset compare to HEWA and BIMI?
MedAvail Holdings' Return-on-Tangible-Asset of -71.32% can be compared against companies in the Healthcare Providers & Services industry. The industry median Return-on-Tangible-Asset is 2.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.51, based on 679 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on MedAvail Holdings and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedAvail Holdings's current Return-on-Tangible-Asset is -71.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedAvail Holdings stock overvalued right now?
MedAvail Holdings (STU:73M) has a current Return-on-Tangible-Asset of -71.32%. The current Return-on-Tangible-Asset is -71.32%. MedAvail Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For MedAvail Holdings (STU:73M), the current Return-on-Tangible-Asset is -71.32% as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedAvail Holdings Business Description

Address 4720 East Cotton Gin Loop, Suite 220, Phoenix, AZ, USA, 85040
MedAvail Holdings Inc is a telehealth-enabled pharmacy technology company. It operates in two segments: Retail Pharmacy Services and Pharmacy Technology. It generates the majority of revenue from the Retail Pharmacy Services segment, which is into operating SpotRx, a full-service retail pharmacy utilizing MedAvail's automated pharmacy technology, servicing Medicare patients in the United States. The Pharmacy Technology segment develops and commercializes the MedCenter for direct sale or lease to third-party customers.
12GF Score

Get the complete analysis for STU:73M

Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.05
Price